Company / Inventory
Veracyte, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$20.5M
FY2025
5-year range
$11.2M / $21.8M
FY2021-FY2025
Trend
-5.5%
vs FY2024
Sector context
#105 of 118
Health Care
What the data says
Veracyte, Inc.'s inventory of $21M is lower than 89% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $3M in FY2018 to $22M in FY2024.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +34.6%.
Improved from $16M to $21M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- +34.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 118This company $20.5M Sector average $1.4B
▼
-98.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.6%, indicating consistent growth.
- In FY2025, inventory decreased 5.5% year-over-year.
- Ranks #105 out of 118 companies in the Health Care sector.
- Peak inventory was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.5M | -5.5% |
| FY2024 | $21.8M | +34.9% |
| FY2023 | $16.1M | +12.8% |
| FY2022 | $14.3M | +27.3% |
| FY2021 | $11.2M | +141.0% |
| FY2020 | $4.7M | -31.6% |
| FY2019 | $6.8M | +100.1% |
| FY2018 | $3.4M | -36.1% |
| FY2017 | $5.3M | +53.2% |
| FY2016 | $3.5M | -7.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026